126.88
price up icon1.91%   2.38
after-market アフターアワーズ: 126.88
loading
前日終値:
$124.50
開ける:
$126.055
24時間の取引高:
7.36M
Relative Volume:
1.08
時価総額:
$220.05B
収益:
$41.95B
当期純損益:
$13.40B
株価収益率:
16.59
EPS:
7.65
ネットキャッシュフロー:
$6.35B
1週間 パフォーマンス:
+1.96%
1か月 パフォーマンス:
-4.36%
6か月 パフォーマンス:
+9.27%
1年 パフォーマンス:
+13.84%
1日の値動き範囲:
Value
$124.04
$128.52
1週間の範囲:
Value
$120.47
$128.52
52週間の値動き範囲:
Value
$99.71
$140.84

Abbott Laboratories Stock (ABT) Company Profile

Name
名前
Abbott Laboratories
Name
セクター
Healthcare (1156)
Name
電話
(224) 667-6100
Name
住所
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Name
職員
114,000
Name
Twitter
@AbbottNews
Name
次回の収益日
2025-04-16
Name
最新のSEC提出書
Name
ABT's Discussions on Twitter

ABT を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Medical Devices icon
ABT
Abbott Laboratories
126.88 220.05B 41.95B 13.40B 6.35B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
93.67 138.54B 16.75B 1.85B 2.37B 1.25
Medical Devices icon
SYK
Stryker Corp
350.28 132.98B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
82.90 105.84B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
69.40 39.98B 5.72B 4.17B 259.90M 6.97

Abbott Laboratories Stock (ABT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-10-08 開始されました Oppenheimer Outperform
2024-09-19 開始されました Piper Sandler Overweight
2024-07-30 ダウングレード Edward Jones Buy → Hold
2024-05-30 開始されました Goldman Buy
2023-07-21 アップグレード Wolfe Research Underperform → Peer Perform
2023-05-30 ダウングレード Morgan Stanley Overweight → Equal-Weight
2023-04-20 繰り返されました Barclays Overweight
2023-04-20 繰り返されました Bernstein Outperform
2023-04-20 繰り返されました JP Morgan Overweight
2023-04-20 繰り返されました Raymond James Outperform
2023-04-20 繰り返されました UBS Buy
2023-04-20 繰り返されました Wolfe Research Underperform
2023-03-29 開始されました UBS Buy
2022-10-26 開始されました Mizuho Neutral
2022-10-18 開始されました Barclays Overweight
2022-10-12 開始されました Jefferies Hold
2022-07-06 開始されました Wolfe Research Underperform
2022-03-02 再開されました BofA Securities Buy
2022-01-27 繰り返されました Credit Suisse Outperform
2022-01-27 繰り返されました Morgan Stanley Overweight
2022-01-27 繰り返されました Raymond James Outperform
2022-01-27 繰り返されました UBS Buy
2021-12-10 開始されました RBC Capital Mkts Outperform
2021-10-27 アップグレード Atlantic Equities Neutral → Overweight
2021-10-14 開始されました Redburn Neutral
2021-05-25 開始されました Barclays Overweight
2021-04-15 開始されました Atlantic Equities Neutral
2021-01-28 アップグレード BTIG Research Neutral → Buy
2020-09-11 開始されました Wolfe Research Outperform
2020-06-01 ダウングレード Goldman Neutral → Sell
2020-03-05 開始されました Citigroup Buy
2020-02-13 開始されました Goldman Neutral
2020-02-06 再開されました BTIG Research Neutral
2020-01-02 ダウングレード Guggenheim Buy → Neutral
2019-06-13 繰り返されました BofA/Merrill Buy
2019-02-07 繰り返されました BofA/Merrill Buy
2019-01-02 ダウングレード Citigroup Neutral → Sell
2018-11-30 アップグレード Goldman Neutral → Buy
2018-10-16 開始されました Barclays Overweight
2018-06-27 開始されました Bernstein Outperform
2018-01-30 繰り返されました Citigroup Neutral
2018-01-25 繰り返されました Stifel Buy
2018-01-25 アップグレード William Blair Mkt Perform → Outperform
2018-01-03 開始されました Evercore ISI Outperform
2018-01-02 アップグレード JP Morgan Neutral → Overweight
2018-01-02 アップグレード Morgan Stanley Equal-Weight → Overweight
2017-10-19 繰り返されました RBC Capital Mkts Outperform
2017-10-19 繰り返されました Stifel Buy
すべてを表示

Abbott Laboratories (ABT) 最新ニュース

pulisher
Apr 12, 2025

With 79% ownership of the shares, Abbott Laboratories (NYSE:ABT) is heavily dominated by institutional owners - simplywall.st

Apr 12, 2025
pulisher
Apr 12, 2025

Immunoassay Analyzers Market Size to Hit USD 10.16 Billion by 2032 | SNS Insider - GlobeNewswire Inc.

Apr 12, 2025
pulisher
Apr 11, 2025

Ex-Dividend Reminder: Buckle, AbbVie and Abbott Laboratories - Nasdaq

Apr 11, 2025
pulisher
Apr 11, 2025

Recent Filing Shows That Rep. Josh Gottheimer Sold Over $32K Worth of Abbott Laboratories Stock - Benzinga

Apr 11, 2025
pulisher
Apr 11, 2025

Seeking Clues to Abbott (ABT) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics - Nasdaq

Apr 11, 2025
pulisher
Apr 10, 2025

TD Cowen maintains Abbott Labs stock Buy rating, $135 target - Investing.com India

Apr 10, 2025
pulisher
Apr 10, 2025

TD Cowen maintains Abbott Labs stock Buy rating, $135 target By Investing.com - Investing.com UK

Apr 10, 2025
pulisher
Apr 10, 2025

Abbott's Q1 Earnings Coming Up, Medical Devices Arm in Focus - Zacks Investment Research

Apr 10, 2025
pulisher
Apr 10, 2025

Immunoassay Market to Witness Remarkable Growth with Abbott - openPR.com

Apr 10, 2025
pulisher
Apr 09, 2025

Positive Outlook for Abbott Laboratories: Strong Growth and New Product Launches Support Buy Rating - TipRanks

Apr 09, 2025
pulisher
Apr 09, 2025

Will Trump Tariffs Make or Break Healthcare Space? 3 Stocks to Rely On - TradingView

Apr 09, 2025
pulisher
Apr 09, 2025

Abbott (ABT) Earnings Expected to Grow: Should You Buy? - Yahoo Finance

Apr 09, 2025
pulisher
Apr 09, 2025

Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

Apr 09, 2025
pulisher
Apr 09, 2025

Abbott Laboratories' (NYSE:ABT) institutional investors lost 5.9% over the past week but have profited from longer-term gains - Yahoo Finance

Apr 09, 2025
pulisher
Apr 08, 2025

Abbott bolsters its Heart Failure leadership - MassDevice

Apr 08, 2025
pulisher
Apr 08, 2025

Cytokine Market Is Booming So Rapidly 2025-2032 -Abbott, AB - openPR.com

Apr 08, 2025
pulisher
Apr 08, 2025

Oppenheimer maintains Abbott stock Outperform with $134 target By Investing.com - Investing.com India

Apr 08, 2025
pulisher
Apr 08, 2025

Oppenheimer maintains Abbott stock Outperform with $134 target - Investing.com

Apr 08, 2025
pulisher
Apr 08, 2025

The Zacks Analyst Blog Highlights Molson Coors, CenterPoint Energy, WEC Energy, Abbott Laboratories and HCA Healthcare - Yahoo Finance

Apr 08, 2025
pulisher
Apr 07, 2025

Is Abbott Laboratories (ABT) the Most Profitable Dividend Stock to Buy Now? - Insider Monkey

Apr 07, 2025
pulisher
Apr 07, 2025

Citigroup Adjusts Abbott Laboratories Price Target to $155 From $160, Maintains Buy Rating - MarketScreener

Apr 07, 2025
pulisher
Apr 06, 2025

Abbott Laboratories (ABT): One of the Best Dividend Kings to Buy for Safe Dividend Growth - Insider Monkey

Apr 06, 2025
pulisher
Apr 05, 2025

Abbott Laboratories (ABT) Maintains Strong ROE Amid Stock Decline - GuruFocus

Apr 05, 2025
pulisher
Apr 05, 2025

Will Weakness in Abbott Laboratories' (NYSE:ABT) Stock Prove Temporary Given Strong Fundamentals? - Yahoo Finance

Apr 05, 2025
pulisher
Apr 04, 2025

Here’s What to Expect From Abbott Laboratories’ Next Earnings Report - Nasdaq

Apr 04, 2025
pulisher
Apr 04, 2025

Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic? - Yahoo

Apr 04, 2025
pulisher
Apr 04, 2025

Piper Sandler maintains Overweight on Abbott Labs with $133 target - Investing.com

Apr 04, 2025
pulisher
Apr 04, 2025

Reasons to Add ABT Stock to Your Portfolio Right Now - TradingView

Apr 04, 2025
pulisher
Apr 04, 2025

Q4 Rundown: Abbott Laboratories (NYSE:ABT) Vs Other Medical Devices & SuppliesDiversified Stocks - Yahoo Finance

Apr 04, 2025
pulisher
Apr 04, 2025

Unsanitary Practices Persist at Baby Formula Factory Whose Shutdown Led to Mass Shortages, Workers Say - ProPublica

Apr 04, 2025
pulisher
Apr 04, 2025

Leadless Pacemakers Market Deep Research 2025-2032 | Abbott - openPR.com

Apr 04, 2025
pulisher
Apr 03, 2025

Impact of Trump tariffs on med tech proving difficult to anticipate - BioWorld MedTech

Apr 03, 2025
pulisher
Apr 03, 2025

Global Expansion in EPD and Innovations Support Abbott Stock - Nasdaq

Apr 03, 2025
pulisher
Apr 03, 2025

Similac infant formula class action alleges products contain heavy metals - Class Action Lawsuits

Apr 03, 2025
pulisher
Apr 03, 2025

FISH Probe Market Is Booming So Rapidly 2025-2032Abbott Laboratories, Agilent Technologies Inc - openPR.com

Apr 03, 2025
pulisher
Apr 02, 2025

Hematology Diagnostics Market is Booming Worldwide | Abbott, Boule Diagnostics, and Danaher are the Major Stakeholders – Arizton - Barchart.com

Apr 02, 2025
pulisher
Apr 02, 2025

Abbott Laboratories consolidates media with Spark Foundry - Ad Age

Apr 02, 2025
pulisher
Apr 02, 2025

Abbott launches next-gen delivery system for Proclaim DRG neurostim - MassDevice

Apr 02, 2025
pulisher
Apr 01, 2025

Abbott joins AFib-treating race with tech that may skip general anesthesia - Star Tribune

Apr 01, 2025
pulisher
Apr 01, 2025

Abbott Laboratories (NYSE:ABT) Shows Promising Results in Heart Valve Device Study - simplywall.st

Apr 01, 2025
pulisher
Apr 01, 2025

Hematology Market Is Booming Worldwide | Abbott Laboratories, Sysmex Co., Beckman Coulter, Horiba - openPR.com

Apr 01, 2025
pulisher
Apr 01, 2025

ABT Stock Gains Following the Positive TRILUMINATE Trial Results - TradingView

Apr 01, 2025
pulisher
Mar 31, 2025

ABC's 'Abbott Elementary' teams up with MilliporeSigma to bring mobile science lab to San Jose elementary school students - ABC7 San Francisco

Mar 31, 2025
pulisher
Mar 31, 2025

Abbott (ABT) Outperforms Broader Market: What You Need to Know - Yahoo Finance

Mar 31, 2025
pulisher
Mar 31, 2025

Sector Update: Health Care Stocks Mixed in Afternoon Trading - MarketScreener

Mar 31, 2025
pulisher
Mar 31, 2025

Abbott Laboratories’ TriClip Device: A Promising Investment Backed by Positive TRILUMINATE Trial Results - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

Abbott TriClip offers substantial improvements in study - MassDevice

Mar 31, 2025
pulisher
Mar 31, 2025

Abbott Laboratories Says Trial Results Show Benefits of TriClip System for People With Leaky Heart Valves - MarketScreener

Mar 31, 2025
pulisher
Mar 31, 2025

The Zacks Analyst Blog Highlights McDonald's, Abbott Laboratories, O'Reilly Automotive and MIND Technology - Yahoo Finance

Mar 31, 2025
pulisher
Mar 31, 2025

Abbott's Revolutionary Heart Valve Treatment Cuts Hospitalizations by 27% in Landmark Trial - Stock Titan

Mar 31, 2025
pulisher
Mar 31, 2025

Abbott Laboratories’ SWOT analysis: stock outlook amid PFA system approval - Investing.com

Mar 31, 2025

Abbott Laboratories (ABT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
medical_devices BSX
$93.67
price up icon 1.11%
medical_devices SYK
$350.28
price up icon 0.54%
medical_devices MDT
$82.90
price up icon 0.44%
medical_devices EW
$69.40
price up icon 1.67%
$62.81
price up icon 0.85%
大文字化:     |  ボリューム (24 時間):